ARDS, Human, COVID-19, Pneumonia, Respiratory Failure, Ventilatory Failure
Conditions
Brief summary
This study uses the AirGo band to monitor changes in tidal ventilation in spontaneously breathing patients with COVID-19 associated respiratory failure. It aims to recognize patterns of ventilation associated with worsening respiratory failure in this patient population. If successful, this study will lead to the development of new robust methods for real-time, continuous monitoring of respiratory function in patients with respiratory failure. In turn, such monitoring methods may enable improvements in the medical management of respiratory failure and timing of interventions.
Interventions
DEVICEAirGo Respiratory Monitor
AirGo™ is composed of a wearable, miniaturized recorder unit and a medical grade Holter worn over the floating ribs of patients both at rest and during normal activity. The recorder measures live circumference changes.
Sponsors
Massachusetts General Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Admitted to the hospital * ≥ 18 years of age * Clinically suspected or confirmed COVID-19 infection * Spontaneously breathing * For patients not on supplemental oxygen at their location of residence prior to hospital admission, need for supplemental O2 to maintain SpO2 \>=92% * For patients on supplemental O2 at their location of residence prior to hospital admission, an increase in requirement of supplemental oxygen from baseline
Exclusion criteria
* Intubated patients * Pregnant women * Moribund patients * Patients who are on comfort measures (CMO)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Endotracheal intubation during present hospitalization, recorded through chart review | Up to three weeks | Progression of respiratory failure to require endotracheal intubation (and mechanical ventilation) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in hypoxemia as indicated by oxygen saturation and requirement for supplemental oxygen, recorded through chart review | Up to three weeks | Maintenance of SpO2 \>=90% on no or low flow supplemental oxygen (=\< 1 liter by nasal cannula or CPAP, or return of supplemental oxygen to baseline if required supplemental O2 for another indication, prior to onset of COVID-19 infection) |
| Premature need for removal of the band, recorded through investigator report | Up to three weeks | Patient or care provider may request removal of the band for any reason prior to the patient reaching the outcome |
| In-hospital mortality, recorded through chart review | Up to 24 weeks | Death from any cause while in the hospital |
Countries
United States
Outcome results
None listed